Related Experiment Video
Updated: Aug 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
IL-1-Activated Inflammatory Cardiac Fibroblasts Exacerbate Acute Coxsackievirus B3 Myocarditis
David S Elias1, Wonyoung Jo1, Monica V Talor1
1Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
We investigated how inflammatory fibroblasts (IFs) contribute to acute viral myocarditis, a dangerous inflammatory heart disease often caused by infections like coxsackievirus B3 (CVB3). Using CCL2-mCherry reporter mice, we tracked IF kinetics during CVB3 infection and discovered that their activity peaks on day 3 of myocarditis and is characterized by the production of Th1, Th2, and Th17 chemokines rather than typical profibrotic genes. We identified IL-1β as the most potent activator of this inflammatory state. We generated PDGFRαcreIL1r1fl/fl mice to specifically delete IL-1 signaling in fibroblasts. This targeted deletion reduced total cardiac inflammation by 45%-specifically lowering monocytes, T cells, and NK cells-without affecting viral clearance. By confirming the presence of IFs in endomyocardial biopsies from human patients, we have shown that fibroblast-specific IL-1 signaling is a critical driver of disease and a potential therapeutic target.
Insights
Inflammatory fibroblasts (IFs) drive viral myocarditis by producing chemokines, not profibrotic genes. Targeting IL-1 signaling in these fibroblasts significantly reduces heart inflammation, offering a potential therapeutic strategy for this dangerous heart condition.
Area of Science:
- Cardiology
- Immunology
- Fibroblast Biology
Background:
- Acute viral myocarditis is a severe heart condition often triggered by viral infections like coxsackievirus B3 (CVB3).
- The role of inflammatory fibroblasts (IFs) in the pathogenesis of viral myocarditis is not fully understood.
- Identifying specific molecular pathways driving IF activation is crucial for therapeutic development.
Purpose of the Study:
- To investigate the kinetics and functional role of inflammatory fibroblasts (IFs) in acute viral myocarditis.
- To identify key molecular signals that activate IFs during myocarditis.
- To evaluate the therapeutic potential of targeting fibroblast-specific signaling pathways.
Main Methods:
- Utilized CCL2-mCherry reporter mice to track IFs during CVB3-induced myocarditis.
- Analyzed chemokine and gene expression profiles of IFs.
- Generated and studied PDGFRαcreIL1r1fl/fl mice with fibroblast-specific deletion of IL-1 receptor signaling.
- Examined endomyocardial biopsies from human patients.
Main Results:
- IFs exhibited peak activity on day 3 of myocarditis, producing Th1, Th2, and Th17 chemokines.
- Interleukin-1 beta (IL-1β) was identified as a potent activator of IFs.
- Targeted deletion of IL-1 signaling in fibroblasts reduced cardiac inflammation by 45%, decreasing monocytes, T cells, and NK cells, without impacting viral clearance.
- IFs were confirmed in human myocardial biopsies.
Conclusions:
- Fibroblast-specific IL-1 signaling is a critical driver of cardiac inflammation in viral myocarditis.
- IFs contribute to myocarditis pathogenesis through chemokine production rather than profibrotic activity.
- Targeting fibroblast IL-1 signaling represents a promising therapeutic strategy for viral myocarditis.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management
